Skip to search boxSkip to navigationSkip to main content

Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: Results of the adaptive CRT trial

  • David O. Martin(corresponding author)
    ,
  • Bernd Lemke
    ,
  • David Birnie
    ,
  • Henry Krum
    ,
  • Kathy Lai Fun Lee
    ,
  • Kazutaka Aonuma
*Corresponding author for this work
  • Cleveland Clinic Foundation
    ,
  • Klinikum Lüdenscheid
    ,
  • University of Ottawa
    ,
  • Monash University
    ,
  • The University of Hong Kong
    ,
  • University of Tsukuba
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

Background: In patients with sinus rhythm and normal atrioventricular conduction, pacing only the left ventricle with appropriate atrioventricular delays can result in superior left ventricular and right ventricular function compared with standard biventricular (BiV) pacing. Objective: To evaluate a novel adaptive cardiac resynchronization therapy ((aCRT) algorithm for CRT pacing that provides automatic ambulatory selection between synchronized left ventricular or BiV pacing with dynamic optimization of atrioventricular and interventricular delays. Methods: Patients (n = 522) indicated for a CRT-defibrillator were randomized to aCRT vs echo-optimized BiV pacing (Echo) in a 2:1 ratio and followed at 1-, 3-, and 6-month postrandomization. Results: The study met all 3 noninferiority primary objectives: (1) the percentage of aCRT patients who improved in their clinical composite score at 6 months was at least as high in the aCRT arm as in the Echo arm (73.6% vs 72.5%, with a noninferiority margin of 12%; P =.0007); (2) aCRT and echo-optimized settings resulted in similar cardiac performance, as demonstrated by a high concordance correlation coefficient between aortic velocity time integrals at aCRT and Echo settings at randomization (concordance correlation coefficient = 0.93; 95% confidence interval 0.91-0.94) and at 6-month postrandomization (concordance correlation coefficient = 0.90; 95% confidence interval 0.87-0.92); and (3) aCRT did not result in inappropriate device settings. There were no significant differences between the arms with respect to heart failure events or ventricular arrhythmia episodes. Secondary end points showed similar benefit, and right-ventricular pacing was reduced by 44% in the aCRT arm. Conclusions: The aCRT algorithm is safe and at least as effective as BiV pacing with comprehensive echocardiographic optimization.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1807-1814.e1

Journal (Volume, Issue Number)

Heart Rhythm (Volume 9, Issue 11)

Publication milestones

  • Published - 11/01/2012

Publication status

Published - 11/01/2012

ISSN

1547-5271

Publication IDs

  • Scopus: 84867859165
  • PubMed: 22796472

Publication metrics

Metrics

SciVal
citations
155
Fractional count
1
Fractional count
0.01
Fractional count
99
Fractional count
0.99
Fractional count
1
Fractional count
1
Scopus
citations
SciVal
FWCI
5.00
SciVal
Author count
100
SciVal
Paper percentile
98
SciVal
Top percentile
5

PlumX, opens in new tab

Citation count
230
Captures
144

Funding Details

The trial was sponsored by Medtronic, Mounds View, Minnesota. Dr Martin serves on a Medtronic advisory board. Dr Lemke has received honoraria and speaker's fees from Medtronic and Saint Jude Medical and speaker's fees from Boston Scientific. Dr Birnie has received honoraria and research grants from Medtronic . Dr Krum has received honoraria from Medtronic. Dr Lee has received research grants from Medtronic . Dr Aonuma has received honoraria, speaker's fees, and research grants from Medtronic . Dr Gasparini has received honoraria and served on advisory boards for Medtronic and Boston Scientific. Dr Starling has received honoraria from Novartis. Dr Milasinovic has received honoraria from Medtronic. Dr Gorcsan has consulted for or has received research grants from Biotronik , Medtronic , St Jude Medical , GE , and Toshiba Medical . T. Rogers is a statistician employed by Medtronic. A. Sambelashvili is a scientist employed by Medtronic.
FundersFunding numbers
Medtronic
-
SJM
-
Biotronik
-